Cyr61/CCN1 targets for chemosensitization in pancreatic cancer
Cyr61/CCN1 targets for chemosensitization in pancreatic cancer |
https://doi.org/10.18632/oncotarget.26986
Snigdha Banerjee,
Arnab Ghosh,
Daniel D. VonHoff,
and Sushanta K. Banerjee
|
3579-3580 |
Elevated telomere dysfunction in cells containing the African-centric Pro47Ser cancer-risk variant of TP53
Elevated telomere dysfunction in cells containing the African-centric Pro47Ser cancer-risk variant of TP53 |
https://doi.org/10.18632/oncotarget.26980
Stephen Tutton,
Zhong Deng,
Nitish Gulve,
Olga Vladimirova,
Kate Beishline,
Andreas Wiedmer,
Maureen Murphy,
and Paul M. Lieberman
|
3581-3591 |
Flow based single cell analysis of the immune landscape distinguishes Barrett’s esophagus from adjacent normal tissue
Flow based single cell analysis of the immune landscape distinguishes Barrett’s esophagus from adjacent normal tissue |
https://doi.org/10.18632/oncotarget.26911
Moen Sen,
Friedrich Hahn,
Taylor A. Black,
Maureen DeMarshall,
Warren Porter,
Eileen Snowden,
Stephanie S. Yee,
Frances Tong,
Mitchell Ferguson,
Emylee N. Fleshman,
Hiroshi Nakagawa,
Gary W. Falk,
Gregory G. Ginsberg,
Michael L. Kochman,
Rainer Blaesius,
Anil K. Rustgi,
and Erica L. Carpenter
|
3592-3604 |
Prognostic significance of the pretreatment prognostic nutritional index in patients with epithelial ovarian cancer
Prognostic significance of the pretreatment prognostic nutritional index in patients with epithelial ovarian cancer |
https://doi.org/10.18632/oncotarget.26914
Naoko Komura,
Seiji Mabuchi,
Eriko Yokoi,
Kotaro Shimura,
Mahiru Kawano,
Yuri Matsumoto,
and Tadashi Kimura
|
3605-3613 |
Molecular characterization of carcinosarcomas arising in the uterus and ovaries
Molecular characterization of carcinosarcomas arising in the uterus and ovaries |
https://doi.org/10.18632/oncotarget.26942
Marta Brunetti,
Antonio Agostini,
Julie Staurseth,
Ben Davidson,
Sverre Heim,
and Francesca Micci
|
3614-3624 |
A three-step approach identifies novel shear stress-sensitive endothelial microRNAs involved in vasculoprotective effects of high-intensity interval training (HIIT)
A three-step approach identifies novel shear stress-sensitive endothelial microRNAs involved in vasculoprotective effects of high-intensity interval training (HIIT) |
https://doi.org/10.18632/oncotarget.26944
Boris Schmitz,
Franziska L. Breulmann,
Bothaynah Jubran,
Florian Rolfes,
Lothar Thorwesten,
Michael Krüger,
Andreas Klose,
Hans-Joachim Schnittler,
and Stefan-Martin Brand
|
3625-3640 |
Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes
Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes |
https://doi.org/10.18632/oncotarget.26950
Nadin D. Exner,
Jaime Alberto Campos Valenzuela,
Khalil Abou-El-Ardat,
Hrvoje Miletic,
Peter C. Huszthy,
Petra M. Radehaus,
Evelin Schröck,
Rolf Bjerkvig,
Lars Kaderali,
Barbara Klink,
and Janice M. Nigro
|
3641-3653 |
Development, validation, and comparison of gene analysis methods for detecting EGFR mutation from non-small cell lung cancer patients-derived circulating free DNA
Development, validation, and comparison of gene analysis methods for detecting EGFR mutation from non-small cell lung cancer patients-derived circulating free DNA |
https://doi.org/10.18632/oncotarget.26951
Masaki Hanibuchi,
Akira Kanoh,
Takuya Kuramoto,
Tatsuro Saito,
Makoto Tobiume,
Atsuro Saijo,
Hiroyuki Kozai,
Mayo Kondo,
Shun Morizumi,
Hiroto Yoneda,
Kozo Kagawa,
Hirokazu Ogino,
Seidai Sato,
Hiroshi Kawano,
Kenji Otsuka,
Yuko Toyoda,
Hiroshi Nokihara,
Hisatsugu Goto,
and Yasuhiko Nishioka
|
3654-3666 |
PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer
PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer |
https://doi.org/10.18632/oncotarget.26960
Sandeep Rajput,
Zhanfang Guo,
Shunqiang Li,
and Cynthia X. Ma
|
3667-3680 |
Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential
Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential |
https://doi.org/10.18632/oncotarget.26978
Balraj Singh,
Vanessa N. Sarli,
Hannah E. Kinne,
Anna Shamsnia,
and Anthony Lucci
|
3681-3693 |
Cancer-testis antigens MAGEA proteins are incorporated into extracellular vesicles released by cells
Cancer-testis antigens MAGEA proteins are incorporated into extracellular vesicles released by cells |
https://doi.org/10.18632/oncotarget.26979
Anneli Kuldkepp,
Magda Karakai,
Eve Toomsoo,
Olavi Reinsalu,
and Reet Kurg
|
3694-3708 |
Functional interplay between YY1 and CARM1 promotes oral carcinogenesis
Functional interplay between YY1 and CARM1 promotes oral carcinogenesis |
https://doi.org/10.18632/oncotarget.26984
Amit K. Behera,
Manoj Kumar,
Muthu K. Shanmugam,
Aditya Bhattacharya,
Vinay J. Rao,
Akshay Bhat,
Madavan Vasudevan,
Kodaganur S. Gopinath,
Azeem Mohiyuddin,
Anupam Chatterjee,
Gautam Sethi,
and Tapas K. Kundu
|
3709-3724 |
1,4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours
1,4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours |
https://doi.org/10.18632/oncotarget.26966
Clare T. Butler,
Susan A. Kennedy,
Amy Buckley,
Ronan Doyle,
Emer Conroy,
William M. Gallagher,
Jacintha O’Sullivan,
and Breandán N. Kennedy
|
3725-3744 |
Dissecting the role of RNA modification regulatory proteins in melanoma
Dissecting the role of RNA modification regulatory proteins in melanoma |
https://doi.org/10.18632/oncotarget.26959
Parmanand Malvi,
Biao Wang,
Shreni Shah,
and Romi Gupta
|
3745-3759 |
Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification
Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification |
https://doi.org/10.18632/oncotarget.26940
Shan-Ju Yeh,
Chien-An Chang,
Cheng-Wei Li,
Lily Hui-Ching Wang,
and Bor-Sen Chen
|
3760-3806 |
Association study of apelin-APJ system genetic polymorphisms with incident metabolic syndrome in a Chinese population: a case-control study
Association study of apelin-APJ system genetic polymorphisms with incident metabolic syndrome in a Chinese population: a case-control study |
https://doi.org/10.18632/oncotarget.24111
Meijin Zhang,
Feng Peng,
Liming Lin,
Mingzhong Yu,
Chengyuan Huang,
Dan Hu,
Qinghui Guo,
Changsheng Xu,
and Jinxiu Lin
|
3807-3817 |
Regression of BRAFV600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases
Regression of BRAFV600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases |
https://doi.org/10.18632/oncotarget.26932
Peter Y.M. Woo,
Tai-Chung Lam,
Jenny K.S. Pu,
Lai-Fung Li,
Roland C.Y. Leung,
Jason M.K. Ho,
James T.F. Zhung,
Belinda Wong,
Timonthy S.K. Chan,
Herbert H.F. Loong,
and Ho-Keung Ng
|
3818-3826 |
Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL
Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL |
https://doi.org/10.18632/oncotarget.27011
John C. Byrd,
Stephen Smith,
Nina Wagner-Johnston,
Jeff Sharman,
Andy I. Chen,
Ranjana Advani,
Bradley Augustson,
Paula Marlton,
S. Renee Commerford,
Kwame Okrah,
Lichuan Liu,
Elaine Murray,
Elicia Penuel,
Ashley F. Ward,
and Ian W. Flinn
|
3827-3830 |